HYPERHEP BS/D (GRIFOLS USA, LLC)


Welcome to the PulseAid listing for the HYPERHEP B drug offered from GRIFOLS USA, LLC. This Human Immunoglobulin [EPC],Passively Acquired Immunity [PE],Virus Neutralization [MoA],Virus-specific Hyperimmune Globulins [Chemical/Ingredient],Immunoglobulins [Chemical/Ingredient] pharmaceutical is classified as a PLASMA DERIVATIVE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same PLASMA DERIVATIVE drug type category.
LABELER NAME / MANUFACTURER: GRIFOLS USA, LLC
NON-PROPRIETARY NAME: HEPATITIS B IMMUNE GLOBULIN (HUMAN)
SUBSTANCE NAME: HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN
TYPE: PLASMA DERIVATIVE
PHARMA CLASS: Human Immunoglobulin [EPC],Passively Acquired Immunity [PE],Virus Neutralization [MoA],Virus-specific Hyperimmune Globulins [Chemical/Ingredient],Immunoglobulins [Chemical/Ingredient]
ROUTE: INTRAMUSCULAR
DOSAGE FORM: INJECTION
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 1996-10-09
END MARKETING DATE: 0000-00-00


HYPERHEP B S/D PLASMA DERIVATIVE Details:

Item DescriptionHYPERHEP B S/D from GRIFOLS USA, LLC
LABELER NAME: GRIFOLS USA, LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 220([iU]/mL)
START MARKETING DATE: 1996-10-09
END MARKETING DATE: 0000-00-00
PRODUCT ID: 13533-636_5e516db1-4145-44b5-8152-f884040c1755
PRODUCT NDC: 13533-636
APPLICATION NUMBER: BLA101146

Other HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Aptevo BioTherapeutics LLCHepaGam B
Biotest Pharmaceuticals CorporationNABI-HB
Cangene bioPharma Inc.HepaGam B
Cangene BioPharma, LLCHepaGam B
GRIFOLS USA, LLCHYPERHEP B